Oncolytics Biotech Inc. (ONC.TO)
CAD 1.1
(-2.65%)
CAD 1.1
(-2.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.41 CAD | 4.65% |
| 2022 | -0.43 CAD | 12.24% |
| 2021 | -0.49 CAD | -2.08% |
| 2020 | -0.48 CAD | 76.7% |
| 2019 | -2.06 CAD | -94.34% |
| 2018 | -1.06 CAD | 5.36% |
| 2017 | -1.12 CAD | 6.67% |
| 2016 | -1.20 CAD | -3.45% |
| 2015 | -1.16 CAD | 42.29% |
| 2014 | -2.01 CAD | 25.0% |
| 2013 | -2.68 CAD | 40.97% |
| 2012 | -4.54 CAD | -16.71% |
| 2011 | -3.89 CAD | -27.96% |
| 2010 | -3.04 CAD | 7.32% |
| 2009 | -3.28 CAD | 18.61% |
| 2008 | -4.03 CAD | -9.51% |
| 2007 | -3.68 CAD | 1.6% |
| 2006 | -3.74 CAD | -0.81% |
| 2005 | -3.71 CAD | 13.92% |
| 2004 | -4.31 CAD | -23.85% |
| 2003 | -3.48 CAD | -27.01% |
| 2002 | -2.74 CAD | 13.56% |
| 2001 | -3.17 CAD | -51.67% |
| 2000 | -2.09 CAD | -124.73% |
| 1999 | -0.93 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.10 CAD | -4.15% |
| 2024 Q1 | -0.09 CAD | -70.9% |
| 2023 FY | - CAD | 4.65% |
| 2023 Q1 | -0.10 CAD | 30.0% |
| 2023 Q2 | -0.12 CAD | -22.45% |
| 2023 Q4 | -0.05 CAD | 61.71% |
| 2023 Q3 | -0.14 CAD | -16.67% |
| 2022 Q4 | -0.14 CAD | -85.19% |
| 2022 Q3 | -0.08 CAD | 14.38% |
| 2022 FY | - CAD | 12.24% |
| 2022 Q1 | -0.13 CAD | 7.14% |
| 2022 Q2 | -0.09 CAD | 32.08% |
| 2021 Q1 | -0.13 CAD | 31.58% |
| 2021 FY | - CAD | -2.08% |
| 2021 Q4 | -0.14 CAD | -58.01% |
| 2021 Q3 | -0.09 CAD | 31.85% |
| 2021 Q2 | -0.13 CAD | 0.0% |
| 2020 FY | - CAD | 76.7% |
| 2020 Q4 | -0.19 CAD | -18.75% |
| 2020 Q3 | -0.16 CAD | 5.88% |
| 2020 Q2 | -0.17 CAD | -1800.0% |
| 2020 Q1 | 0.01 CAD | 101.85% |
| 2019 Q1 | -0.27 CAD | -3.85% |
| 2019 FY | - CAD | -94.34% |
| 2019 Q4 | -0.54 CAD | -237.5% |
| 2019 Q3 | -0.16 CAD | 38.46% |
| 2019 Q2 | -0.26 CAD | 3.7% |
| 2018 Q2 | -0.27 CAD | 12.9% |
| 2018 Q3 | -0.20 CAD | 25.93% |
| 2018 FY | - CAD | 5.36% |
| 2018 Q4 | -0.26 CAD | -30.0% |
| 2018 Q1 | -0.31 CAD | 3.13% |
| 2017 FY | - CAD | 6.67% |
| 2017 Q4 | -0.32 CAD | -60.0% |
| 2017 Q3 | -0.20 CAD | 37.5% |
| 2017 Q2 | -0.32 CAD | -14.29% |
| 2017 Q1 | -0.28 CAD | 31.71% |
| 2016 Q3 | -0.26 CAD | -30.0% |
| 2016 Q1 | -0.32 CAD | -14.29% |
| 2016 FY | - CAD | -3.45% |
| 2016 Q4 | -0.41 CAD | -57.69% |
| 2016 Q2 | -0.20 CAD | 37.5% |
| 2015 Q4 | -0.28 CAD | -21.74% |
| 2015 Q2 | -0.32 CAD | 5.88% |
| 2015 Q1 | -0.34 CAD | 5.56% |
| 2015 FY | - CAD | 42.29% |
| 2015 Q3 | -0.23 CAD | 28.13% |
| 2014 Q3 | -0.50 CAD | 3.85% |
| 2014 Q1 | -0.61 CAD | 6.15% |
| 2014 Q4 | -0.36 CAD | 28.0% |
| 2014 Q2 | -0.52 CAD | 14.75% |
| 2014 FY | - CAD | 25.0% |
| 2013 Q2 | -0.56 CAD | 29.11% |
| 2013 FY | - CAD | 40.97% |
| 2013 Q4 | -0.65 CAD | 5.8% |
| 2013 Q3 | -0.69 CAD | -23.21% |
| 2013 Q1 | -0.79 CAD | 24.76% |
| 2012 Q1 | -1.08 CAD | 30.77% |
| 2012 Q2 | -1.26 CAD | -16.67% |
| 2012 FY | - CAD | -16.71% |
| 2012 Q3 | -1.15 CAD | 8.73% |
| 2012 Q4 | -1.05 CAD | 8.7% |
| 2011 Q3 | -0.83 CAD | 13.54% |
| 2011 FY | - CAD | -27.96% |
| 2011 Q1 | -0.54 CAD | 46.53% |
| 2011 Q2 | -0.96 CAD | -77.78% |
| 2011 Q4 | -1.56 CAD | -87.95% |
| 2010 Q4 | -1.01 CAD | -62.9% |
| 2010 Q3 | -0.62 CAD | 7.46% |
| 2010 Q2 | -0.67 CAD | -4.69% |
| 2010 FY | - CAD | 7.32% |
| 2010 Q1 | -0.64 CAD | 20.99% |
| 2009 Q3 | -0.52 CAD | 40.23% |
| 2009 FY | - CAD | 18.61% |
| 2009 Q1 | -0.86 CAD | 20.37% |
| 2009 Q2 | -0.87 CAD | -1.16% |
| 2009 Q4 | -0.81 CAD | -55.77% |
| 2008 Q4 | -1.08 CAD | -12.5% |
| 2008 FY | - CAD | -9.51% |
| 2008 Q1 | -0.77 CAD | 18.09% |
| 2008 Q2 | -1.21 CAD | -57.14% |
| 2008 Q3 | -0.96 CAD | 20.66% |
| 2007 Q2 | -0.85 CAD | 16.67% |
| 2007 FY | - CAD | 1.6% |
| 2007 Q4 | -0.94 CAD | -5.62% |
| 2007 Q3 | -0.89 CAD | -4.71% |
| 2007 Q1 | -1.02 CAD | 16.39% |
| 2006 FY | - CAD | -0.81% |
| 2006 Q3 | -0.89 CAD | -14.1% |
| 2006 Q2 | -0.78 CAD | 1.27% |
| 2006 Q4 | -1.22 CAD | -37.08% |
| 2006 Q1 | -0.79 CAD | -19.7% |
| 2005 Q1 | -0.70 CAD | 41.18% |
| 2005 Q2 | -0.85 CAD | -21.43% |
| 2005 FY | - CAD | 13.92% |
| 2005 Q3 | -1.17 CAD | -37.65% |
| 2005 Q4 | -0.66 CAD | 43.59% |
| 2004 Q1 | -0.93 CAD | -57.63% |
| 2004 Q4 | -1.19 CAD | -50.63% |
| 2004 Q2 | -1.05 CAD | -12.9% |
| 2004 Q3 | -0.79 CAD | 24.76% |
| 2004 FY | - CAD | -23.85% |
| 2003 Q1 | -0.48 CAD | 30.43% |
| 2003 FY | - CAD | -27.01% |
| 2003 Q4 | -0.59 CAD | 14.49% |
| 2003 Q3 | -0.69 CAD | 58.43% |
| 2003 Q2 | -1.66 CAD | -245.83% |
| 2002 Q1 | -0.63 CAD | 10.0% |
| 2002 FY | - CAD | 13.56% |
| 2002 Q4 | -0.69 CAD | 22.47% |
| 2002 Q3 | -0.89 CAD | -41.27% |
| 2002 Q2 | -0.63 CAD | 0.0% |
| 2001 FY | - CAD | -51.67% |
| 2001 Q2 | -0.70 CAD | -27.27% |
| 2001 Q3 | -1.26 CAD | -80.0% |
| 2001 Q1 | -0.55 CAD | -96.43% |
| 2001 Q4 | -0.70 CAD | 44.44% |
| 2000 Q1 | -0.15 CAD | 0.0% |
| 2000 Q2 | -0.71 CAD | -373.33% |
| 2000 Q3 | -0.85 CAD | -19.72% |
| 2000 Q4 | -0.28 CAD | 67.06% |
| 2000 FY | - CAD | -124.73% |
| 1999 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Appili Therapeutics Inc. | -0.03 CAD | -1214.103% |
| Eupraxia Pharmaceuticals Inc. | -1.58 CAD | 74.051% |
| Helix BioPharma Corp. | -0.21 CAD | -95.238% |
| Microbix Biosystems Inc. | -0.00 CAD | -136566.667% |
| Medicenna Therapeutics Corp. | -0.37 CAD | -10.811% |
| Satellos Bioscience Inc. | -0.18 CAD | -127.778% |
| Sernova Corp. | -0.13 CAD | -215.385% |